KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Assets Average (2016 - 2025)

Historic Assets Average for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to $135.5 billion.

  • AbbVie's Assets Average fell 500.39% to $135.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $135.5 billion, marking a year-over-year decrease of 500.39%. This contributed to the annual value of $134.9 billion for FY2024, which is 133.23% down from last year.
  • Latest data reveals that AbbVie reported Assets Average of $135.5 billion as of Q3 2025, which was down 500.39% from $136.7 billion recorded in Q2 2025.
  • Over the past 5 years, AbbVie's Assets Average peaked at $150.5 billion during Q1 2021, and registered a low of $135.0 billion during Q2 2023.
  • In the last 5 years, AbbVie's Assets Average had a median value of $141.8 billion in 2024 and averaged $141.4 billion.
  • In the last 5 years, AbbVie's Assets Average soared by 6696.76% in 2021 and then plummeted by 600.53% in 2025.
  • Quarter analysis of 5 years shows AbbVie's Assets Average stood at $147.7 billion in 2021, then decreased by 5.17% to $140.1 billion in 2022, then decreased by 3.28% to $135.5 billion in 2023, then rose by 2.82% to $139.3 billion in 2024, then fell by 2.69% to $135.5 billion in 2025.
  • Its last three reported values are $135.5 billion in Q3 2025, $136.7 billion for Q2 2025, and $135.7 billion during Q1 2025.